Free Trial
NYSE:BTX

Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis

Brooklyn ImmunoTherapeutics logo
$6.92 -0.01 (-0.14%)
As of 11:04 AM Eastern

About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX)

Key Stats

Today's Range
$6.89
$6.94
50-Day Range
$5.52
$6.92
52-Week Range
$5.10
$8.31
Volume
196,614 shs
Average Volume
749,764 shs
Market Capitalization
$407.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.

Receive BTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

BTX Stock News Headlines

Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
'Brooklyn Nine-Nine' star Andre Braugher dies at 61
Brooklyn Bridge
Brooklyn Bedding Coupon for November
See More Headlines

BTX Stock Analysis - Frequently Asked Questions

Brooklyn ImmunoTherapeutics' stock was trading at $0.2940 on January 1st, 2025. Since then, BTX stock has increased by 2,253.7% and is now trading at $6.92.
View the best growth stocks for 2025 here
.

Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brooklyn ImmunoTherapeutics investors own include Mastech Digital (MHH), Mastech Digital (MHH), Altimeter Growth Corp. 2 (AGCB), African Gold Acquisition (AGAC), Aldel Financial (ADF) and Adit EdTech Acquisition (ADEX).

Company Calendar

Record date for 3/31 Dividend
3/14/2025
Ex-Dividend for 3/31 Dividend
3/14/2025
Dividend Payable
3/31/2025
Today
5/27/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
Television Broadcasting
Sub-Industry
N/A
Current Symbol
NYSE:BTX
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$40.69 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$407.08 million
Optionable
No Data
Beta
4.61
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:BTX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners